News & Updates

Show Multimedia Only

What is the most cost-effective CRC screening strategy in Asians?

26 Oct 2025 by

Faecal immunochemical test (FIT) positive result followed by artificial intelligence (AI)–assisted colonoscopy represents the most cost-effective colorectal cancer (CRC) screening strategy in an Asian population, according to a study from the Chinese University of Hong Kong (CUHK).

What is the most cost-effective CRC screening strategy in Asians?

26 Oct 2025

Nanocurcumin may prevent chemo-induced cardiotoxicity in breast cancer patients

25 Oct 2025

Supplementation with nanocurcumin appears to reduce the cardiotoxicity of anthracycline chemotherapy medication in breast cancer patients, suggests a study.

Nanocurcumin may prevent chemo-induced cardiotoxicity in breast cancer patients

25 Oct 2025

Azole antifungals safe, effective in patients on midostaurin for FLT3 AML

24 Oct 2025

The use of azole antifungal medications concurrently or sequentially with midostaurin is both safe and effective for patients with newly diagnosed FMS-like tyrosine kinase 3 mutated (FLT3m) acute myeloid leukaemia (AML), reports a study.

Azole antifungals safe, effective in patients on midostaurin for FLT3 AML

24 Oct 2025

High incidence of chemo-related ADRs noted in multiple myeloma patients

24 Oct 2025

A single-institution study has found a notably high incidence of chemotherapy-related adverse drug reactions (ADRs) in patients with multiple myeloma.

High incidence of chemo-related ADRs noted in multiple myeloma patients

24 Oct 2025

Polygenic risk score shows promise in predicting future breast cancer events

23 Oct 2025 by

A retrospective analysis shows the potential of the 313-SNP breast cancer (BC) polygenic risk score (PRS313) blood test to predict future in situ or invasive breast disease in women diagnosed with ductal carcinoma in situ (DCIS) or lobular carcinoma in situ (LCIS).

Polygenic risk score shows promise in predicting future breast cancer events

23 Oct 2025

Adjuvant cemiplimab prolongs DFS in cutaneous SCC

22 Oct 2025 by

In the phase III C-POST trial, adjuvant cemiplimab prolongs disease-free survival (DFS) in individuals at high risk for recurrence of cutaneous squamous cell carcinoma (cSCC).

Adjuvant cemiplimab prolongs DFS in cutaneous SCC

22 Oct 2025

Cardiac irradiation, anthracyclines linked to VHD risk in childhood cancer survivors

21 Oct 2025

Higher doses of heart radiation therapy (RT) and anthracyclines contribute to an increased risk of valvular heart disease (VHD) in childhood cancer survivors, as suggested in a nested case-control study.

Cardiac irradiation, anthracyclines linked to VHD risk in childhood cancer survivors

21 Oct 2025

Early check-in protocol improves adherence to anticancer medications

20 Oct 2025

The implementation of an early check-in protocol may enable pharmacists of health-system specialty pharmacies (HSSPs) to enhance patient adherence to oral anticancer medication (OAM), suggests a recent study.

Early check-in protocol improves adherence to anticancer medications

20 Oct 2025

Deep learning-based model shows promise for personalizing ESCC treatment

17 Oct 2025 by

A retrospective analysis shows the ability of Vision-Mamba (Vim), a novel deep-learning (DL) model, to predict pathologic complete response (pCR) in individuals with esophageal squamous cell carcinoma (ESCC) following neoadjuvant immunotherapy and chemotherapy (nICT).

Deep learning-based model shows promise for personalizing ESCC treatment

17 Oct 2025

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

14 Oct 2025

The toll-like receptor 9 agonist nelitolimod, when combined with pembrolizumab, shows promising antitumour activity in treatment-naïve patients with anti–PD-1/PD-L1 advanced melanoma, according to a phase II open-label trial.

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

14 Oct 2025

News & Updates

Showing Oncology articles

Showing

Specialty:

What is the most cost-effective CRC screening strategy in Asians?

What is the most cost-effective CRC screening strategy in Asians?

Nanocurcumin may prevent chemo-induced cardiotoxicity in breast cancer patients

Nanocurcumin may prevent chemo-induced cardiotoxicity in breast cancer patients

Azole antifungals safe, effective in patients on midostaurin for FLT3 AML

Azole antifungals safe, effective in patients on midostaurin for FLT3 AML

High incidence of chemo-related ADRs noted in multiple myeloma patients

High incidence of chemo-related ADRs noted in multiple myeloma patients

Polygenic risk score shows promise in predicting future breast cancer events

Polygenic risk score shows promise in predicting future breast cancer events

Adjuvant cemiplimab prolongs DFS in cutaneous SCC

Adjuvant cemiplimab prolongs DFS in cutaneous SCC

Cardiac irradiation, anthracyclines linked to VHD risk in childhood cancer survivors

Cardiac irradiation, anthracyclines linked to VHD risk in childhood cancer survivors

Early check-in protocol improves adherence to anticancer medications

Early check-in protocol improves adherence to anticancer medications

Deep learning-based model shows promise for personalizing ESCC treatment

Deep learning-based model shows promise for personalizing ESCC treatment

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma

Frontline nelitolimod plus pembrolizumab combo elicits response in advanced melanoma